Pediatric versus adult meningioma: comparison of epidemiology, treatments, and outcomes using the Surveillance, Epidemiology, and End Results database
- 9 March 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 137 (3) , 621-629
Abstract
Pediatric meningiomas, which account for < 1% of all meningiomas, are thought to have unique features, including being more aggressive than their adult counterparts. The goal of this investigation was to compare pediatric and adult meningiomas in a large head-to-head comparison. We used the Surveillance, Epidemiology, and End Result (SEER) datasets to compare meningioma demographics, first treatments, and outcomes among children/adolescents (0–21 years), young adults (22–45 years), and older adults (> 45 years). During 2004–2012, SEER contained 59148 patients age 0–107 years diagnosed with meningioma, with children/adolescents accounting for 381 (0.64%) patients. Unlike older and young adults, children/adolescents with meningioma did not demonstrate female predominance, and had an equal 1:1 male-to-female ratio. Children/adolescents also had almost three-times as many spinal tumors (13.1%) than young adults (4.2%) and older adults (4.4%). Both children/adolescents and young adults had undergone more gross total resections (both 43%) versus older adults (25%), and were treated more with radiation (14.6%, and 12.0% respectively) than their older counterparts (8.5%). In addition, both children/adolescents and young adults had significantly lower all-cause mortality (4.5% in both) than older adults (24.6%), during median 35-month follow-up. Inherent limitations of the SEER datasets restrict our ability to answer important questions regarding comparisons of tumor grading, histological diagnosis, cause-specific mortality, and neurofibromatosis status. Pediatric meningiomas appear distinct from their adult counterparts as they do not display the typical female predominance and include more clinically relevant spinal tumors. More extensive surgeries, greater use of radiation therapy, and lower all-cause mortality were seen in both children/adolescents and young adults, which raises questions regarding the perceived uniquely aggressive nature of pediatric meningiomas. However, due to the significant limitations of the SEER datasets, our results must be interpreted cautiously and stand only to foster novel questions, which would be better answered in well-designed, prospective studies.Keywords
Funding Information
- Morgan Adams Foundation
- The Hartford Foundation for Public Giving
- Colorado Clinical and Translational Sciences Institute
- Children’s Hospital Colorado Research Institute (NCATS/NIH UL1 TR001082)
- National Cancer Institute (R03 CA212800-01)
This publication has 48 references indexed in Scilit:
- Meningiomas in children and adolescents: a meta-analysis of individual patient dataThe Lancet Oncology, 2011
- Treatment and survival of patients with nonmalignant intracranial meningioma: results from the Surveillance, Epidemiology, and End Results Program of the National Cancer InstituteJournal of Neurosurgery, 2011
- Primary Extracranial Meningiomas: An Analysis of 146 CasesHead and Neck Pathology, 2009
- Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patientsJournal of Neurosurgery, 2005
- Earliest Clinical Manifestations and Natural History of Neurofibromatosis Type 2 (NF2) in Childhood: A Study of 24 PatientsNeuropediatrics, 2005
- Long-term follow up of children with meningiomas in Denmark: 1935 to 1984Journal of neurosurgery. Pediatrics, 2004
- Meningeal Tumors in ChildrenPediatric Neurosurgery, 1994
- Intracranial Meningiomas in ChildrenPediatric Neurosurgery, 1985
- Clinical and pathological study of meningiomas of the first two decades of lifeJournal of Neurosurgery, 1982
- Normal ages of pubertal events among American males and femalesJournal of Adolescent Health Care, 1980